NICE’s latest technology appraisal of the flu antiviral drugs (amantadine, oseltamivir and zanamivir), published in February 2009 marks the sixth time these drugs have been considered. The timelines are shown […]
NICE’s latest technology appraisal of the flu antiviral drugs (amantadine, oseltamivir and zanamivir), published in February 2009 marks the sixth time these drugs have been considered. The timelines are shown […]